{"id":450144,"date":"2021-03-03T17:05:45","date_gmt":"2021-03-03T22:05:45","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=450144"},"modified":"2021-03-03T17:05:45","modified_gmt":"2021-03-03T22:05:45","slug":"hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-to-securities-fraud-investigation-and-encourages-investors-with-losses-to-contact-its-attorneys","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-to-securities-fraud-investigation-and-encourages-investors-with-losses-to-contact-its-attorneys\/","title":{"rendered":"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Athenex (ATNX) Investors to Securities Fraud Investigation and Encourages Investors with Losses to Contact Its Attorneys"},"content":{"rendered":"
\n

SAN FRANCISCO, March 03, 2021 (GLOBE NEWSWIRE) — Hagens Berman urges Athenex, Inc. (NASDAQ: ATNX) <\/strong>investors with significant losses to submit your losses now<\/a>. The firm is investigating possible securities law violations and certain investors may have valuable claims.<\/p>\n\n\n\n\n
\n Visit:<\/strong>
\n www.hbsslaw.com\/investor-fraud\/ATNX<\/a>
\n \n <\/td>\n<\/tr>\n
\n Contact An Attorney Now:<\/strong>\n <\/td>\n\n ATNX@hbsslaw.com<\/a>\u00a0<\/td>\n<\/tr>\n
\u00a0<\/td>\n\n 844-916-0895<\/strong>\n <\/td>\n<\/tr>\n<\/table>\n

\n Athenex, Inc. (NASDAQ: ATNX) Investigation: <\/strong>\n <\/p>\n

The investigation centers on the accuracy of Athenex\u2019s disclosures about clinical trials and safety and efficacy data within the new drug application (\u201cNDA\u201d) for the company\u2019s Oraxol, a drug intended to treat metastatic breast cancer.<\/p>\n

In past quarters, the company emphasized the positive feedback it had received from the FDA on the Phase III clinical trials for Oraxol, \u201cwhich provides further validation of our regulatory pathway for Oraxol.\u201d<\/p>\n

Then, on Mar. 1, 2021, Athenex announced it received the FDA\u2019s complete response letter (\u201cCRL\u201d) to the NDA. According to the company, the FDA indicated the NDA for the proposed drug is not ready for approval in its present form and recommended the company \u201cconduct a new adequate and well-conducted clinical trial in a patient population with metastatic breast cancer representative of the population in the U.S.\u201d<\/p>\n

Moreover, the FDA raised concerns about safety risks to patients and the uncertainty over the results of the primary endpoint of objective response rate conducted by blinded independent central review.<\/p>\n

This news sent the price of Athenex shares sharply lower.<\/p>\n

\u201cWe\u2019re focused on investors\u2019 losses and whether Athenex may have intentionally misled investors about communications with the FDA concerning Oraxol,\u201d said Reed Kathrein, the Hagens Berman partner leading the investigation.<\/p>\n

If you are an Athenex investor and have significant losses, or have knowledge that may assist the firm\u2019s investigation, click here to discuss your legal rights with Hagens Berman<\/a>.<\/p>\n

\n Whistleblowers: <\/strong>Persons with non-public information regarding Athenex should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895<\/strong> or email ATNX@hbsslaw.com<\/a>.<\/p>\n

\n
\n About Hagens Berman<\/u>
\n <\/a>
\n
Hagens Berman is a national law firm with nine offices in eight cities around the country and eighty attorneys. The firm represents investors, whistleblowers, workers and consumers in complex litigation.\u00a0\u00a0 More about the firm and its successes is located at hbsslaw.com<\/a>. For the latest news visit our newsroom<\/u><\/a> or follow us on Twitter at @classactionlaw<\/u><\/a>.<\/p>\n

\n Contact: <\/u>
\n
Reed Kathrein, 844-916-0895<\/p>\n

\u00a0<\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

SAN FRANCISCO, March 03, 2021 (GLOBE NEWSWIRE) — Hagens Berman urges Athenex, Inc. (NASDAQ: ATNX) investors with significant losses to submit your losses now. The firm is investigating possible securities law violations and certain investors may have valuable claims. Visit: www.hbsslaw.com\/investor-fraud\/ATNX Contact An Attorney Now: ATNX@hbsslaw.com\u00a0 \u00a0 844-916-0895 Athenex, Inc. (NASDAQ: ATNX) Investigation: The investigation centers on the accuracy of Athenex\u2019s disclosures about clinical trials and safety and efficacy data within the new drug application (\u201cNDA\u201d) for the company\u2019s Oraxol, a drug intended to treat metastatic breast cancer. In past quarters, the company emphasized the positive feedback it had received from the FDA on the Phase III clinical trials for Oraxol, \u201cwhich provides further validation of our regulatory pathway for … <\/p>\n

Continue reading “HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Athenex (ATNX) Investors to Securities Fraud Investigation and Encourages Investors with Losses to Contact Its Attorneys”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-450144","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nHAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Athenex (ATNX) Investors to Securities Fraud Investigation and Encourages Investors with Losses to Contact Its Attorneys - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-to-securities-fraud-investigation-and-encourages-investors-with-losses-to-contact-its-attorneys\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Athenex (ATNX) Investors to Securities Fraud Investigation and Encourages Investors with Losses to Contact Its Attorneys - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN FRANCISCO, March 03, 2021 (GLOBE NEWSWIRE) — Hagens Berman urges Athenex, Inc. (NASDAQ: ATNX) investors with significant losses to submit your losses now. The firm is investigating possible securities law violations and certain investors may have valuable claims. Visit: www.hbsslaw.com\/investor-fraud\/ATNX Contact An Attorney Now: ATNX@hbsslaw.com\u00a0 \u00a0 844-916-0895 Athenex, Inc. (NASDAQ: ATNX) Investigation: The investigation centers on the accuracy of Athenex\u2019s disclosures about clinical trials and safety and efficacy data within the new drug application (\u201cNDA\u201d) for the company\u2019s Oraxol, a drug intended to treat metastatic breast cancer. In past quarters, the company emphasized the positive feedback it had received from the FDA on the Phase III clinical trials for Oraxol, \u201cwhich provides further validation of our regulatory pathway for … Continue reading "HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Athenex (ATNX) Investors to Securities Fraud Investigation and Encourages Investors with Losses to Contact Its Attorneys"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-to-securities-fraud-investigation-and-encourages-investors-with-losses-to-contact-its-attorneys\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-03T22:05:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDA0OCM0MDQ3NTE1IzIwMTg1MzI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-to-securities-fraud-investigation-and-encourages-investors-with-losses-to-contact-its-attorneys\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-to-securities-fraud-investigation-and-encourages-investors-with-losses-to-contact-its-attorneys\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Athenex (ATNX) Investors to Securities Fraud Investigation and Encourages Investors with Losses to Contact Its Attorneys\",\"datePublished\":\"2021-03-03T22:05:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-to-securities-fraud-investigation-and-encourages-investors-with-losses-to-contact-its-attorneys\\\/\"},\"wordCount\":443,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-to-securities-fraud-investigation-and-encourages-investors-with-losses-to-contact-its-attorneys\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NDA0OCM0MDQ3NTE1IzIwMTg1MzI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-to-securities-fraud-investigation-and-encourages-investors-with-losses-to-contact-its-attorneys\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-to-securities-fraud-investigation-and-encourages-investors-with-losses-to-contact-its-attorneys\\\/\",\"name\":\"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Athenex (ATNX) Investors to Securities Fraud Investigation and Encourages Investors with Losses to Contact Its Attorneys - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-to-securities-fraud-investigation-and-encourages-investors-with-losses-to-contact-its-attorneys\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-to-securities-fraud-investigation-and-encourages-investors-with-losses-to-contact-its-attorneys\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NDA0OCM0MDQ3NTE1IzIwMTg1MzI=\",\"datePublished\":\"2021-03-03T22:05:45+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-to-securities-fraud-investigation-and-encourages-investors-with-losses-to-contact-its-attorneys\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-to-securities-fraud-investigation-and-encourages-investors-with-losses-to-contact-its-attorneys\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-to-securities-fraud-investigation-and-encourages-investors-with-losses-to-contact-its-attorneys\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NDA0OCM0MDQ3NTE1IzIwMTg1MzI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NDA0OCM0MDQ3NTE1IzIwMTg1MzI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-to-securities-fraud-investigation-and-encourages-investors-with-losses-to-contact-its-attorneys\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Athenex (ATNX) Investors to Securities Fraud Investigation and Encourages Investors with Losses to Contact Its Attorneys\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Athenex (ATNX) Investors to Securities Fraud Investigation and Encourages Investors with Losses to Contact Its Attorneys - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-to-securities-fraud-investigation-and-encourages-investors-with-losses-to-contact-its-attorneys\/","og_locale":"en_US","og_type":"article","og_title":"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Athenex (ATNX) Investors to Securities Fraud Investigation and Encourages Investors with Losses to Contact Its Attorneys - Market Newsdesk","og_description":"SAN FRANCISCO, March 03, 2021 (GLOBE NEWSWIRE) — Hagens Berman urges Athenex, Inc. (NASDAQ: ATNX) investors with significant losses to submit your losses now. The firm is investigating possible securities law violations and certain investors may have valuable claims. Visit: www.hbsslaw.com\/investor-fraud\/ATNX Contact An Attorney Now: ATNX@hbsslaw.com\u00a0 \u00a0 844-916-0895 Athenex, Inc. (NASDAQ: ATNX) Investigation: The investigation centers on the accuracy of Athenex\u2019s disclosures about clinical trials and safety and efficacy data within the new drug application (\u201cNDA\u201d) for the company\u2019s Oraxol, a drug intended to treat metastatic breast cancer. In past quarters, the company emphasized the positive feedback it had received from the FDA on the Phase III clinical trials for Oraxol, \u201cwhich provides further validation of our regulatory pathway for … Continue reading \"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Athenex (ATNX) Investors to Securities Fraud Investigation and Encourages Investors with Losses to Contact Its Attorneys\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-to-securities-fraud-investigation-and-encourages-investors-with-losses-to-contact-its-attorneys\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-03T22:05:45+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDA0OCM0MDQ3NTE1IzIwMTg1MzI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-to-securities-fraud-investigation-and-encourages-investors-with-losses-to-contact-its-attorneys\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-to-securities-fraud-investigation-and-encourages-investors-with-losses-to-contact-its-attorneys\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Athenex (ATNX) Investors to Securities Fraud Investigation and Encourages Investors with Losses to Contact Its Attorneys","datePublished":"2021-03-03T22:05:45+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-to-securities-fraud-investigation-and-encourages-investors-with-losses-to-contact-its-attorneys\/"},"wordCount":443,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-to-securities-fraud-investigation-and-encourages-investors-with-losses-to-contact-its-attorneys\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDA0OCM0MDQ3NTE1IzIwMTg1MzI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-to-securities-fraud-investigation-and-encourages-investors-with-losses-to-contact-its-attorneys\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-to-securities-fraud-investigation-and-encourages-investors-with-losses-to-contact-its-attorneys\/","name":"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Athenex (ATNX) Investors to Securities Fraud Investigation and Encourages Investors with Losses to Contact Its Attorneys - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-to-securities-fraud-investigation-and-encourages-investors-with-losses-to-contact-its-attorneys\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-to-securities-fraud-investigation-and-encourages-investors-with-losses-to-contact-its-attorneys\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDA0OCM0MDQ3NTE1IzIwMTg1MzI=","datePublished":"2021-03-03T22:05:45+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-to-securities-fraud-investigation-and-encourages-investors-with-losses-to-contact-its-attorneys\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-to-securities-fraud-investigation-and-encourages-investors-with-losses-to-contact-its-attorneys\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-to-securities-fraud-investigation-and-encourages-investors-with-losses-to-contact-its-attorneys\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDA0OCM0MDQ3NTE1IzIwMTg1MzI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDA0OCM0MDQ3NTE1IzIwMTg1MzI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-to-securities-fraud-investigation-and-encourages-investors-with-losses-to-contact-its-attorneys\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Athenex (ATNX) Investors to Securities Fraud Investigation and Encourages Investors with Losses to Contact Its Attorneys"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/450144","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=450144"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/450144\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=450144"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=450144"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=450144"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}